Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: A comparison with patients known to have sustained ventricular tachycardia

Journal of the American College of Cardiology

Volumn 34, Issue 7, 1999, Pages 2023-2030

  Andrews, Neil P ^a   Fogel, Richard I ^a   Pelargonio, Gemma ^a   Evans, Joseph J ^a   Prystowsky, Eric N ^a  

^a Care Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PRIORITY JOURNAL; SYNCOPE;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; SYNCOPE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0033429407     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00465-9     Document Type: Article

References (29)

1. Kapoor W.N., Karpf M., Wieand S., et al. A prospective evaluation and follow up of patients with syncope. N Engl J Med. 309:1983;197-204.
2. Brugada P., Green M., Abdollah H., Wellens H.J.J. Significance of ventricular arrhythmias initiated by programmed ventricular stimulation the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required . Circulation. 69:1984;87-92.
3. Prystowsky E.N. Electrophysiologic-electropharmacologic testing in patients with ventricular arrhythmias. PACE. 11:1988;225-251.
4. Kushner J.A., Kou W.H., Kadish A.H., Morady F. Natural history of patients with unexplained syncope and a non-diagnostic electrophysiologic study. J Am Coll Cardiol. 14:1989;391-396.
5. Fujimura O., Yee R., Klein G.J., et al. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia. N Engl J Med. 321:1989;1703-1707.
6. Zipes D.P., Akhtar M., Denes P., et al. Guidelines for clinical intracardiac electrophysiologic studies. J Am Coll Cardiol. 14:1989;1827-1842.
7. Klein G.J., Gersh B.J., Yee R. Electrophysiological testing the final court of appeal for diagnosis of syncope? Circulation. 92:1995;1332-1335.
8. Gregoratos G., Cheiltin M.D., Conil A., et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices a report of the ACC/AHA Task Force on Practice Guidelines (Committee on Pacemaker Implantation) . J Am Coll Cardiol. 31:1998;1175-1206.
9. Schaal S.F., Nelson S.D., Boudoulas H., Lewis R.P. Syncope. Curr Probl Cardiol. 17:1992;205-264.
10. Gulamhusein S., Naccerelli G.V., Ko P.T., et al. Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope. Am J Med. 73:1982;700-705.
11. Krol R.B., Morady F., Flaker G.C., et al. Electrophysiologic testing in patients with unexplained syncope clinical and non-invasive predictors of outcome . J Am Coll Cardiol. 10:1987;358-363.
12. Bachinsky W.B., Linzer M., Weld L., Estes N.A.M. Usefulness of clinical characteristics in predicting the outcome of electrophysiologic studies in unexplained syncope. Am J Cardiol. 69:1992;1044-1049.
13. DiCarlo L.A., Morady F., Schwartz A.B., et al. Clinical significance of ventricular fibrillation-flutter induced by ventricular programmed stimulation. Am Heart. 109:1985;959-963.
14. Bourke J.P., Richards D.A.B., Ross D.L., et al. Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance? Am J Cardiol. 75:1995;431-435.
15. Englund A., Bergfeldt L., Rehnqvist N., et al. Diagnostic value of programmed ventricular stimulation in patients with bifascicular block a prospective study of patients with and without syncope . J Am Coll Cardiol. 26:1995;1508-1515.
16. Buxton A.E., Fisher J.D., Josephson M.E., et al. Prevention of sudden death in patients with coronary artery disease the Multicenter Unsustained Tachycardia Trial (MUSTT) . Prog Cardiovasc Dis. 36:1993;57-62.
17. Bass E.B., Elson J.J., Fogoros R.N., et al. Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. Am J Cardiol. 62:1988;1186-1191.
18. Doherty J.U., Pembrook-Rogers D., Grogan E.W., et al. Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and near syncope. Am J Cardiol. 55:1985;703-708.
19. Denes P., Uretz E., Ezri M.D., Borbola J. Clinical predictors of electrophysiologic findings in patients with syncope of unknown origin. Arch Intern Med. 148:1988;1922-1928.
20. Click R.L., Gersh B.J., Sugrue D.D., et al. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol. 59:1987;817-823.
21. Lacroix D., Dubuc M., Kus T., et al. Evaluation of arrhythmic causes of syncope correlation between Holter monitoring, electrophysiologic testing and body surface mapping . Am Heart J. 122:1991;1346-1354.
22. Hook B.G., Callans D.J., Kleiman R.B., et al. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms rhythm diagnosis and management aided by stored electrogram analysis . Circulation. 87:1993;1897-1906.
23. Callans D.J., Hook B.G., Marchlinski F.E. Use of bipolar recordings from patch-patch and rate sensing leads to distinguish ventricular tachycardia from supraventricular rhythms in patients with implantable cardioverter-defibrillators. PACE. 14:1991;1917-1922.
24. Raitt M.H., Dolack G.L., Kudenchuk P.J., et al. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation implications for use of implantable defibrillator . Circulation. 91:1995;1996-2000.
25. Morady F., Shen E., Schwartz A., et al. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing. J Am Coll Cardiol. 2:1983;1053-1059.
26. Sra J.S., Anderson J.A., Sheikh S.H., et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med. 114:1991;1013-1019.
27. Grimm W., Flores B.T., Marchlinski F.E. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation. 87:1993;1880-1888.
28. Link M.S., Costeas X.F., Griffith J.L., et al. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias. J Am Coll Cardiol. 29:1997;370-375.
29. Militianu A., Salacta S., Seibert K., et al. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near syncope. J Cardiovasc Electrophysiol. 8:1997;1087-1097.